SARL Armen Instrument has sold the flash chromatography division to Interchim SA
January 2010 — SARL Armen Instrument has sold its flash chromatography branch of activity to Interchim SA. Financial terms of this transaction have not been disclosed.
This sale will enable Armen Instrument to focus on its core businesses of developing and marketing preparative high-performance chromatography machines with modular and integrated systems, as well as centrifuge partition chromatography and CPC/CCC solutions. Francois Couillard, founder of the company, said: "Armen Instrument's experience in liquid chromatography has culminated in this sale of its flash chromatography business to its strategic partner, Interchim SA. The expertise developed over more than five years of flash chromatography R&D work and the marketing of machines like the SPOT II has been acknowledged by a world-renowned company."
Our role in the transaction
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more